Cybereason, which specializes in end-point detection, runs behavioral analytics on an organization’s network to detect and respond to threats, according to the company’s website.
Lior Div, co-founder and CEO of Cybereason, told CNBC the company will use the funding to expand its products, hire additional employees and increase its office space.
Cybereason has raised $189 million in funding to date, according to CNBC, with investment from Charles River Ventures, Lockheed Martin and Spark Capital. The company declined to disclose its valuation to CNBC.
More articles on health IT:
Michigan to link PDMP with EHRs, pharmacy systems
IBM debuts Watson for Genomics in China
Dr. Sean Tunis elected president of HTAi
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
